Onco-D-Clare is a revolutionary cancer screening blood test to detect cancer based on each person’s genetic profile at its earliest stages, even before symptoms appear. Through an analysis of the DNA in the bloodstream, this genetic cancer testing method helps individuals stay proactive about their health by identifying potential cancer risks early, when treatment is most effective.
Early tumor detection plays a critical role in cancer treatment and management. Tumors identified at an early stage are often more treatable and associated with better outcomes and lower healthcare costs. The Onco-D-Clare test from RGCC empowers individuals with vital information, offering a non-invasive screening solution for early cancer detection.
Onco-D-Clare is a cancer blood test which uses modern liquid biopsy techniques to check the risk of all types of cancer except brain and CNS (central nervous system) tumors. It is based on the synergy of molecular biology with artificial neural networks. This screening test combines gene expression analysis and machine learning algorithms.
Peripheral blood mononuclear cells are isolated from blood samples, and gene expression analysis is performed on more than 90 genes.
The expression profile is then used to classify the sample as healthy or indicative of a positive immune response to cancer cells.
The Onco-D-Clare test has been clinically validated with an approximate accuracy of 93%
Onco-D-Clare is based on scientific evidence showing that PBMC gene-expression profiling can distinguish normal from cancer-related samples. Find the study here.
Who should get an Onco-D-Clare blood test?
Onco-D-Clare is a test for individuals who do not have a cancer diagnosis but want to stay ahead of potential health challenges. This blood test is especially useful for those who have a family history of cancer or other risk factors.
Test details
Sample type
Peripheral whole blood sample
Analysis period
≈ 7 business days
Cancer type
All types of cancer except brain and CNS (central nervous system) cancers
Final results
7-10 business days after sample delivery
Sample size
5-8 ml of peripheral whole blood
Price*
800 €
* The prices of the tests may be an issue of local additional taxes and value added taxes which are dependent of each country’s legislation. The prices may vary in areas that are under the jurisdiction of a distributor. These prices are for the tests only, and they do not include in-office fees such as consultation, blood draws, etc.
* RGCC is not liable for any third-party comments or claims regarding our products. For accurate and up-to-date information about our offerings, please refer to our official website: rgcc-international.com
